*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Effect of COVID-19 on Cancer: With Special References to Liver Cancer

Author: GHASSAN SALAH AHMED, AHMED S. ABDUL JABBAR, MURTADHA A. JEBER, H. N. K. AL-SALMAN, FALAH HASSAN SHARI, QUTAIBA A. QASIM, HUSSEIN H. HUSSEIN
Abstract: Coronavirus is the irresistible sickness brought about through the Covid, SARS-CoV-2, which is a respiratory microbe. WHO first learned of this new virus from cases in Wuhan, People’s Republic of China on 31 December 2019. People of all ages who experience fever and/or cough associated with trouble breathing or windedness, chest agony or weight, or loss of discourse or development should look for clinical consideration right away. If possible, call your health care provider, hotline or health facility first, so you can be directed to the right clinic. A great many people (about 80%) recuperate from the illness without requiring clinic treatment. About 20% of the individuals who get COVID-19 become truly sick and require oxygen, with 5% turning out to be basically sick and requiring concentrated consideration. Complications leading to death may include respiratory letdown, severerespiratory distress syndrome (SRDS), sepsis and infectedupset, thromboembolism, and/or multiorgan malfunction, including injury of the heart, liver or kidneys. In rare situations, children can develop a severe inflammatory syndrome a few weeks after infection. Anyone with symptoms should be tested, wherever possible. People who do not have symptoms but have had close contact with someone who is, or may be, infected may also consider testing – check with your local health guidelines. While a person is waiting for test results, they should remain isolated from others. Where testing capacity is limited, tests should first be done for those at higher risk of infection, such as health workers, and those at higher risk of severe illness such as older people, especially those living in seniors’ residences or long-term care facilities.In this review, we give a concise diagram of the effect that COVID-19 has in disease development and therapy, and feature the arising need to consider the function of COVID-19 contamination in malignant growth movement and treatment.
Keyword: COVID-19,SARS-CoV-2, PCR, COVID-19 infection in cancer, Acute respiratory distress syndrome (ARDS).
DOI: https://doi.org/10.31838/ijpr/2020.12.04.560
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free